4//SEC Filing
Perfetti Riccardo 4
Accession 0001209191-22-044465
CIK 0001697532other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:39 PM ET
Size
32.6 KB
Accession
0001209191-22-044465
Insider Transaction Report
Form 4
Perfetti Riccardo
Chief Medical Officer
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+134,997→ 134,997 totalExercise: $1.05Exp: 2029-05-12→ Common Stock (134,997 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−50,000→ 0 totalExercise: $2.02Exp: 2032-04-13→ Common Stock (50,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+50,000→ 50,000 totalExercise: $1.05Exp: 2032-04-13→ Common Stock (50,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−32,100→ 0 totalExercise: $4.17Exp: 2032-01-07→ Common Stock (32,100 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+32,100→ 32,100 totalExercise: $1.05Exp: 2031-12-14→ Common Stock (32,100 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+36,495→ 36,495 totalExercise: $1.05Exp: 2030-12-10→ Common Stock (36,495 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−51,666→ 0 totalExercise: $22.20Exp: 2029-12-16→ Common Stock (51,666 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−134,997→ 0 totalExercise: $10.00Exp: 2029-05-12→ Common Stock (134,997 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+32,100→ 32,100 totalExercise: $1.05Exp: 2032-01-07→ Common Stock (32,100 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−32,100→ 0 totalExercise: $9.44Exp: 2031-12-14→ Common Stock (32,100 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−36,495→ 0 totalExercise: $23.15Exp: 2030-12-10→ Common Stock (36,495 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+51,666→ 51,666 totalExercise: $1.05Exp: 2029-12-16→ Common Stock (51,666 underlying)
Footnotes (7)
- [F1]The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
- [F2]Reflects an initial grant of 50,000 Options granted on April 13, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F3]Reflects an initial grant of 32,100 Options granted on January 7, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F4]Reflects an initial grant of 32,100 Options granted on December 14, 2021 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on December 14, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F5]Reflects an initial grant of 36,495 Options granted on December 10, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F6]Reflects an initial grant of 51,666 Options granted on December 16, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 16, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F7]Reflects an initial grant of 170,522 Options granted on May 13, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on May 13, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001775410
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 8:39 PM ET
- Size
- 32.6 KB